Digital Pharma is running out of names. Can an AI help? At Reuters Pharma USA, presenters showed off an AI aimed at reimagining the complex process of pharmaceutical naming.
News Japan follows UK in GSK's comeback tour for Blenrep The revitalisation of GSK's blood cancer therapy Blenrep continues with a second approval, in Japan, as a second-line treatment for multiple myeloma.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.